Concepedia

Publication | Open Access

32 Doses of Bortezomib for Desensitization Is Not Well Tolerated and Is Associated With Only Modest Reductions in Anti-HLA Antibody

DOIFull Paper Access

81

Citations

25

References

2016

Year

Manuel A. Moreno Gonzales, Manish J. Gandhi, Carrie A. Schinstock, Natalie A. Moore, Byron H. Smith, Nong Y. Braaten, Mark D. Stegall
Transplantation

Abstract

These data suggest that 32 doses of BTZ monotherapy was not well tolerated and resulted in only a modest reduction in anti-HLA antibodies.

References

YearCitations

Page 1